{"path":"Images/Pasted image 20231024150856.png","text":"Low dose ASA throughout -_— e Clopidogrel Prasugrel Popidopal (LD 300 mg), ticagrelor followed by 75 mg od. i or restart tirofiban/eptifibatide® . » v v . Ol —_— Dy 7 % 5 4 3 2 -1 46h 0 +46h FU/ discharge Low dose ASA throughout - Clopidogrel Prasugrel Clopidogrell (LD 300 mg), ticagrelor followed by 75 mg o.d. i i or restart cangrelor® =TTy . .p -ttt tt—t—t—t— Dy 7 -6 5 -4 3 2 -1 -l-6h 0 +46h FU/ discharge @ st @ stor @esc Figure 7 Bridging with intravenous antiplatelet agents. ASA, acetylsalicylic acid; FU, follow-up; LD, loading dose; NCS, non-cardiac surgery; o.d, once a day. *Tirofiban: 0.1 pg/kg/min; if creatinine clearance <50 mL/min, adjust to 0.05 pg/kg/min. Eptifibatide: 2.0 p/kg/min; if creatinine clearance is <50 mL/ min, adjust to 1.0 pg/kg/min. \"Until oral P2Yy inhibitor therapy is possible. “Initiate within 72 h from P2Y inhibitor discontinuation at a dose of 0.75 g/ ke/min for a minimum of 48 h and a maximum of 7 days.","libVersion":"0.3.2","langs":"eng"}